$cris
Preliminary data show 6 objective responses in 11 response-evaluable patients in this population:
3 complete remission (CR), 1 CR with partial hematologic recovery (CRh) and 2 morphologic leukemia-free state (MLFS) with on-treatment duration range of 46-324 days
$CRIS Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With AML or MDS - Study: NCT04278768 soon to be active and recruiting in 31 locations including numerous european sites: https://t.co/UzFwjlVXqs
$CRIS Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With AML or MDS - Study: NCT04278768 soon to be active and recruiting in 31 locations including numerous european sites: https://t.co/UzFwjlVXqs